AUROBINDO PHARMA INTRADAY TIPS
Visit this page for Aurobindo Pharma Intraday tips, please see the date and time of recommendation before initiate. Visit link to see more free intraday tips.
AuroPharma Received Final Approval From US Health Regulator To Manufacture Ibuprofen
Aurobindo Pharma received a final approval from US Health Regulator to manufacture Ibuprofen capsules OTC, 200 mg. This medicine is used to relieve pain and reduce fever. The product is expecting to launch in September 2018.
The market size of Ibuprofen capsules OTC is around USD 164 million for the last twelve month ending March 2018.
The pharma company said it has now a total of 373 ANDA (Abbreviated New Drug Application) approvals (340 final approvals, including 17 from Aurolife Pharma LLC and 33 tentative approvals) from the USFDA. Report published on moneycontrol on 07th July 2018.
As per latest report on 28 July 2018 :- Accumulate Aurobindo Pharma, target Rs 700: Achin Goel – Traders can accumulate the stock in the range of Rs 610-617 for the target of Rs 700 with a stop loss below Rs 584, says Achin Goel of Bonanza Portfolio
Aurobindo Pharma gets US FDA nod for ertapenem injection
AuroPharma finally received a approval from US FDA to manufacture and sell ertapenem injection 1g/vial (as per report published on 27th June 2018). The product is expecting to launch in July 2018.
This medicine has an market size of US$ 387 million (records as per last 12 months ending April 2018.
The Injection has an use of infections caused by susceptible bacteria. Used in adults for the prophylaxis of surgical site infection following elective colorectal surgery. Visit this page daily for best Aurobindo Pharma Intraday tips.